Drug | Sensitivity classification | Year 2006–2007 | Year 2008–2009 | ||
---|---|---|---|---|---|
% (n) | IC50, nM | % (n) | IC50, nM | ||
AS | All | 100 (56) | 2.0 (1.5–2.4) | 100 (63) | 2.0 (1.5–2.5) |
Sensitive | 60.7 (34) | 1.4 (1.3–1.6) | 58.7 (37) | 1.4 (1.1–1.8) | |
Declined sensitivity | 39.3 (22) | 3.1 (2.8–3.3) | 41.3 (26) | 3.7 (3.2–4.2) | |
MQ | All | 100 (56) | 30.4 (18.0–42.7) | 100 (63) | 28.8 (16.7–41.0) |
Sensitive | 42.9 (24) | 13.8 (11.3–16.3) | 41.3 (26) | 16.2 (13.2–19.2) | |
Resistant | 57.1 (32) | 51.5 (40.3–62.7) | 58.3 (37) | 58.7 (49.3–68.1) | |
CQ | All | 100 (56) | 69.9 (62.8–77.1) | 100 (63) | 72.3 (65.4–79.2) |
Sensitive | 1.8 (1) | 9.6 | – | – | |
Moderate resistant | 76.8 (43) | 65.9 (59.9–72.0) | 69.8 (44) | 66.6 (62.3–70.8) | |
Highly resistant | 21.4 (12) | 124.3 (108.1–140.6) | 30.2 (19) | 132.3 (68.1–196.5) | |
QN | All | 100 (56) | 236.3 (186.2–286.4) | 100 (63) | 230.5 (164.8–296.2) |
Sensitive | 78.6 (44) | 223.0 (178.6–267.3) | 93.7 (59) | 214.9 (150.4–279.4) | |
Resistant | 21.4 (12) | 648.9 (606.1–691.6) | 6.3 (4)** | 593.6 (491.0–696.2) |